NasdaqCM - Delayed Quote
USD
Tiziana Life Sciences Ltd (TLSA)
0.6102
-0.0589
(-8.80%)
At close: 4:00:00 PM EST
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Gabriele Marco Antonio Cerrone M.B.A.
|
Founder & Executive Chairman | -- | -- | 1972 |
|
Ms. Keeren Shah
|
COO & CFO | -- | -- | 1976 |
|
Dr. Ivor R. Elrifi Ph.D.
|
CEO & Executive Director | 131k | -- | -- |
|
Mr. William Edward Tente M.S.
|
Chief Regulatory Officer | -- | -- | 1958 |
|
Dr. Richard K. Kim M.D.
|
Chief Medical Officer | -- | -- | 1971 |
|
Dr. Napoleone Ferrara M.D.
|
Member of Scientific Advisory Board | -- | -- | 1957 |
Tiziana Life Sciences Ltd
14/15 Conduit Street
London, W1S 2XJ
United Kingdom
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 10
Description
Tiziana Life Sciences Ltd, together with its subsidiaries, engages in the research and development of therapies for neurodegenerative and neuroinflammatory diseases in the United Kingdom and internationally. It develops Foralumab TZLS-401, a human anti-CD3 monoclonal antibody, which is Phase II clinical trial for the treatment of non-active secondary progressive multiple sclerosis, Alzheimer's disease, multi system atrophy, and amyotrophic lateral sclerosis; and TZLS-501, a human anti-IL-6R monoclonal antibody for the treatment of autoimmune and inflammatory diseases. The company is headquartered in London, the United Kingdom.
Corporate Governance
Tiziana Life Sciences Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of
Institutional Shareholder Services (ISS)
Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
